Urologic cancers in Korea

摘要: The incidence and prevalence of prostate kidney cancers have been increasing in Korea during the last decade, a marked improvement survival rates has noted. With substantial proportion diagnosed at an earlier stage disease, landscape urologic cancer treatment characterized by exponential increase number patients receiving surgical treatment. Throughout surgeries performed using minimally invasive methods, with notable robot-assisted surgery.The evaluation management strategies are primarily based on existing evidence-based framework provided international guidelines. adoption clinical application novel techniques systemic agents targeted advanced promptly adopted; accordingly, multidisciplinary options often available for various different stages. At same time, decisions greatly influenced availability healthcare resources, which may be limited due to National Health Insurance reimbursement policy.A racial disparity features appears exist certain among Korean patients, optimal strategy specific population yet confirmed. A national comprehensive database is needed better insight into risk factors, selection sequential strategies, tumor biology outcome patients.